|
|
(9 intermediate revisions by 7 users not shown) |
label / en | label / en |
| Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. | | Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein |
label / ast | label / ast |
| Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. | | Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein |
label / nl | label / nl |
| | Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein |
description / pt | description / pt |
| artigo científico | | artigo científico (publicado na 2007) |
description / pt-br | description / pt-br |
| artigo científico | | artigo científico (publicado na 2007) |
description / hy | description / hy |
| գիտական հոդված | | 2007 թվականի հունվարին հրատարակված գիտական հոդված |
description / uk | description / uk |
| наукова стаття | | наукова стаття, опублікована в січні 2007 |
description / da | description / da |
| videnskabelig artikel | | videnskabelig artikel (udgivet 2007) |
description / fr | description / fr |
| article scientifique | | article scientifique (publié 2007) |
description / hyw | description / hyw |
| | 2007 թուականի Յունուարին հրատարակուած գիտական յօդուած |
description / ur | description / ur |
| | سائنسی مضمون |
description / fa | description / fa |
| | مقالهٔ علمی |
Property / title | Property / title |
| Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. (English)
| | Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein (English) |
| Property / cites work |
| | |
| Property / cites work: Adjuvant therapy in colon cancer--what, when and how? / rank |
| | Normal rank |
| Property / cites work: Adjuvant therapy in colon cancer--what, when and how? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations / rank |
| | Normal rank |
| Property / cites work: Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus / rank |
| | Normal rank |
| Property / cites work: Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I / rank |
| | Normal rank |
| Property / cites work: Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II / rank |
| | Normal rank |
| Property / cites work: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome / rank |
| | Normal rank |
| Property / cites work: The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome / rank |
| | Normal rank |
| Property / cites work: Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? / rank |
| | Normal rank |
| Property / cites work: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Pharmacogenomics: road to anticancer therapeutics nirvana? / rank |
| | Normal rank |
| Property / cites work: Pharmacogenomics: road to anticancer therapeutics nirvana? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan / rank |
| | Normal rank |
| Property / cites work: Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Molecular genetic basis of Gilbert's syndrome / rank |
| | Normal rank |
| Property / cites work: Molecular genetic basis of Gilbert's syndrome / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Role of pharmacogenetics in irinotecan therapy / rank |
| | Normal rank |
| Property / cites work: Role of pharmacogenetics in irinotecan therapy / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Irinotecan pharmacogenetics: is it time to intervene? / rank |
| | Normal rank |
| Property / cites work: Irinotecan pharmacogenetics: is it time to intervene? / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Pharmacogenetics of irinotecan toxicity / rank |
| | Normal rank |
| Property / cites work: Pharmacogenetics of irinotecan toxicity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study / rank |
| | Normal rank |
| Property / cites work: Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer / rank |
| | Normal rank |
| Property / cites work: The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein / rank |
| | Normal rank |
| Property / cites work: Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. / rank |
| | Normal rank |
| Property / cites work: Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. / rank |
| | Normal rank |
| Property / cites work: Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. / rank |
| | Normal rank |
| Property / cites work: Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes / rank |
| | Normal rank |
| Property / cites work: Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis / rank |
| | Normal rank |
| Property / cites work: Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo / rank |
| | Normal rank |
| Property / cites work: Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects / rank |
| | Normal rank |
| Property / cites work: Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28. / rank |
| | Normal rank |
| Property / cites work: Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Flat-fixed dosing of irinotecan: influence on pharmacokinetic and pharmacodynamic variability / rank |
| | Normal rank |
| Property / cites work: Flat-fixed dosing of irinotecan: influence on pharmacokinetic and pharmacodynamic variability / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition / rank |
| | Normal rank |
| Property / cites work: ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response / rank |
| | Normal rank |
| Property / cites work: Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport / rank |
| | Normal rank |
| Property / cites work: Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Role for drug transporters beyond tumor resistance: hepatic functional imaging and genotyping of multidrug resistance transporters for the prediction of irinotecan toxicity / rank |
| | Normal rank |
| Property / cites work: Role for drug transporters beyond tumor resistance: hepatic functional imaging and genotyping of multidrug resistance transporters for the prediction of irinotecan toxicity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer / rank |
| | Normal rank |
| Property / cites work: Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes / rank |
| | Normal rank |
| Property / cites work: Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2. / rank |
| | Normal rank |
| Property / cites work: Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity / rank |
| | Normal rank |
| Property / cites work: Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats / rank |
| | Normal rank |
| Property / cites work: Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea / rank |
| | Normal rank |
| Property / cites work: Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Phase II study of activated charcoal to prevent irinotecan-induced diarrhea / rank |
| | Normal rank |
| Property / cites work: Phase II study of activated charcoal to prevent irinotecan-induced diarrhea / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea / rank |
| | Normal rank |
| Property / cites work: Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion / rank |
| | Normal rank |
| Property / cites work: Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials / rank |
| | Normal rank |
| Property / cites work: Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin / rank |
| | Normal rank |
| Property / cites work: Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Modulation of irinotecan metabolism by ketoconazole / rank |
| | Normal rank |
| Property / cites work: Modulation of irinotecan metabolism by ketoconazole / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor / rank |
| | Normal rank |
| Property / cites work: Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing / rank |
| | Normal rank |
| Property / cites work: Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Caution on pedigree haplotype inference with software that assumes linkage equilibrium / rank |
| | Normal rank |
| Property / cites work: Caution on pedigree haplotype inference with software that assumes linkage equilibrium / reference |
| | |
| Property / language of work or name |
| | |
| Property / language of work or name: English / rank |
| | Normal rank |